Combination chemotherapy with docetaxel and carboplatin for epithelial ovarian cancer
Misawa, H.; Ochiai, K.; Yasuda, M.; Tanaka, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 10): 546-549
2004
ISSN/ISBN: 0047-1852 PMID: 15535305 Document Number: 582529
Document emailed within 1 workday
Related Documents
Kietpeerakool, C.; Tiyayon, J.; Suprasert, P.; Kanjanavanit, R.; Srisomboon, J. 2006: Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer Journal of the Medical Association of Thailand 89(11): 1805-1810Vapattanawong, P. 2006: A comparative study on hematological effects of carboplatin plus cyclophosphamide and carboplatin plus paclitaxel chemotherapy for the first line treatment of epithelial ovarian cancer Journal of the Medical Association of Thailand 89(9): 1357-1361
Oyamada, Y.; Watanabe, H.; Fukunaga, K.; Nakamura, H.; Asano, K.; Hasegawa, N.; Yamaguchi, K. 2003: Effects of docetaxel dosage in combination chemotherapy with carboplatin against advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(12): 1917-1922
Skarlos, D.V.; Aravantinos, G.; Kosmidis, P.; Athanassiadis, A.; Stathopoulos, G.P.; Pavlidis, N.; Bafaloukos, D.; Karphathios, S.; Papakostas, P.; Bamia, C.; Fountzilas, G. 1997: Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study Seminars in Oncology 24(5 Suppl 15: S15
Kietpeerakool, C.; Suprasert, P.; Srisomboon, J. 2005: Adverse affects of paclitaxel and carboplatin combination chemotherapy in epithelial gynecologic cancer Journal of the Medical Association of Thailand 88(3): 301-306
Ozols, R.F. 2000: Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer Seminars in Oncology 27(3 Suppl 7: 3-7
Lehoczky, O.ó; Pulay, T.ás. 2003: Early results of first-line chemotherapy with paclitaxel and carboplatin in patients with epithelial ovarian carcinoma Orvosi Hetilap 144(28): 1381-1384
Tanaka, H.; Umekawa, T.; Nagao, K.; Ishihara, A.; Toyoda, N. 2003: Salvage chemotherapy with a combination of irinotecan hydrochloride and mitomycin C in platinum- and paclitaxel-resistant epithelial ovarian cancer: case reports European Journal of Gynaecological Oncology 24(3-4): 337-340
Kavanagh, J.J.; Nicaise, C. 1989: Carboplatin in refractory epithelial ovarian cancer Seminars in Oncology 16(2 Suppl 5: 45-48
Giannakakis, T.; Kakolyris, S.; Theodoropoulos, E.; Kouroussis, C.; Michailakis, E.; Papadouris, S.; Tsitoura, M.; Kalbakis, K.; Souglakos, J.; Agelaki, S.; Vardakis, N.; Georgoulias, V. 2002: A multicenter phase Ii study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer Anticancer Research 22(6b): 3743-3748
Ozols, R.F. 1999: Chemotherapy for ovarian cancer: beyond paclitaxel plus carboplatin Cancer Journal from Scientific American 5(6): 336-338
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Kawada, J.; Iwase, K.; Deguchi, K.; Higashi, S.; Deguchi, T.; Matsuda, C.; Tamagawa, H.; Omori, K.; Nishikawa, K.; Nomura, M.; Takagi, M.; Fukui, A.; Tanaka, Y. 2012: Analysis of combination chemotherapy with docetaxel and nedaplatin for esophageal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2095-2097
Lund, B.; Hansen, O.P.; Hansen, H.H.; Hansen, M. 1992: Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer Seminars in Oncology 19(1 Suppl 1: 26-29
Closon, M.T.; Verbeke, L.; Kains, J.P.; Tijtgat, J.; Schallier, D. 1995: Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer Anticancer Research 15(2): 591-595
Fujinami, K.; Miura, T.; Takizawa, A.; Osada, Y. 2005: Combination chemotherapy with docetaxel and cisplatin in patients with hormone-refractory prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 51(1): 5-8
Kunisaki, C.; Takahashi, M.; Nagahori, Y.; Makino, H.; Takagawa, R.; Sato, T.; Oshima, T.; Fujii, S.; Kosaka, T.; Ono, H.A.; Akiyama, H.; Shimada, H. 2008: Phase i study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer Anticancer Research 28(4c): 2473-2478
Gatzemeier, U.; Achterrath, W.; Heckmayr, M.; Hossfeld, D.K.; Neuhauss, R.; Reck, M.; Zschaber, R. 1990: Chemotherapy of small cell bronchial cancer with a combination of carboplatin, vincristine and etoposide Pneumologie 44(Suppl 1): 584-585
Ota, T.; Takeshima, N.; Takizawa, K. 2011: Second-line chemotherapy for carboplatin/paclitaxel-refractory ovarian cancer: are multi-agent chemotherapies of little value truly? European Journal of Gynaecological Oncology 32(5): 471-475
Kucukzeybek, Y.; Gorumlu, G.; Karaca, B.; Erten, C.; Cengiz, E.; Kemal Gul, M.; Karabulut, B.; Uslu, R.; Sanli, U.A.; Goker, E. 2008: Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 13(2): 199-203